Abg in Blunt Chest Trauma

Blunt Injury of Thorax Clinical Trial

Official title:
Arterial Blood Gas as an Early Screening Tool for Predicting Lung Injury in Blunt Chest Trauma

Status Not yet recruiting

Clinical Trial Summary

This study aims to determine the value of ABG measurments in patients with blunt chest trauma and its role in prognosis of different outcomes and the results would aid the emergency physicians to speed up the management and reduce the cost of diagnosis

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05886946
Study type	Observational
Source	Assiut University
Contact	asmaa ali mohamed, resident
Phone	01099698364
Email	reemalii7766@gmail.com
Status	Not yet recruiting
Phase
Start date	July 1, 2023
Completion date	August 1, 2024

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT06236113` - Low Dose Ketamine for Blunt Thoracic Trauma	Phase 4
Completed	`NCT03580187` - Nebulized Morphine in Chest Trauma Patients: A Prospective Study	Phase 3
Active, not recruiting	`NCT01367951` - Treatment of Acute, Unstable Chest Wall Injuries	N/A
Recruiting	`NCT05527431` - High Flow Nasal Cannula vs Noninvasive Ventilation in Patients With Hypoxic Respiratory Failure Following Blunt Chest Trauma	N/A
Not yet recruiting	`NCT06316375` - STUMBL Score as a Risk Stratification Tool for Management of Blunt Chest Trauma Patients